Lucid Diagnostics

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$1,163
$828
$1,197
$1,172
Gross Profit
-622
-723
-948
-512
EBITDA
-4,211
-26,678
-11,312
-12,155
EBIT
-4,433
-26,899
-11,534
-12,370
Net Income
-4,439
-26,908
-11,541
-12,371
Net Change In Cash
1,163
828
1,197
1,172
Free Cash Flow
-10,549,000
-12,465,000
-10,130
-10,525
Cash
31,123
25,238
22,358
14,489
Basic Shares
98,989
68,796
57,705
50,374

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$4,346
$2,428
$377
$500
Gross Profit
-3,920
-6,050
-3,237
-85
EBITDA
-44,336
-49,751
-54,235
-27,415
EBIT
-45,503
-52,250
-56,171
-27,419
Net Income
-45,529
-52,666
-56,171
-28,078
Net Change In Cash
4,346
2,428
377
500
Cost of Revenue
-31,182
Free Cash Flow
-44,786
-33,038
-30,593
-18,530
Cash
22,358
18,896
22,474
53,656
Basic Shares
50,516
41,756
36,172
36,057

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
-$0.10
2025-03-31
-$0.16
2024-12-31
-$0.19